RecruitingPHASE1, PHASE2NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Studying Drug- or toxin-induced pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novartis Pharmaceuticals
- Intervention
- LTP(drug)
- Enrollment
- 232 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2024 – 2028
Study locations (29)
- Stanford Medical Center, Stanford, California, United States
- Univ Colorado Hospital, Aurora, Colorado, United States
- U of Kansas Medical Center, Kansas City, Kansas, United States
- Norton Infectious Diseases Specialists, Louisville, Kentucky, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Summit Health Eastside Clinic, Bend, Oregon, United States
- Statcare Pulmonary Consultants, Knoxville, Tennessee, United States
- PPD Development LP, Austin, Texas, United States
- The University of Utah, Salt Lake City, Utah, United States
- Pul Ass Richmond Inc P A R, Richmond, Virginia, United States
- Novartis Investigative Site, Camperdown, New South Wales, Australia
- Novartis Investigative Site, Darlinghurst, New South Wales, Australia
- Novartis Investigative Site, New Lambton Heights, New South Wales, Australia
- Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil
- Novartis Investigative Site, Prague, Czechia
- +14 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06649110 on ClinicalTrials.govOther trials for Drug- or toxin-induced pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07529821Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive PatientsFoundation University Islamabad
- ACTIVE NOT RECRUITINGNCT07312227A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaMassachusetts General Hospital
- ENROLLING BY INVITATIONNANCT07558460Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialIstanbul University - Cerrahpasa
- RECRUITINGPHASE2NCT07318597Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals
- RECRUITINGPHASE1NCT06872112A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionJoseph C. Wu
- RECRUITINGPHASE2NCT06351345129 Xenon Imaging in Patients Treated With SotaterceptBastiaan Driehuys
- RECRUITINGPHASE4NCT07140484Sotatercept in Pulmonary Arterial HypertensionUniversity of Alberta
- RECRUITINGPHASE2NCT07175038A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)AllRock Bio, Inc.
See all trials for Drug- or toxin-induced pulmonary arterial hypertension →